Floatz logo

182 assets in Multiple Sclerosis

Therapeutic assets addressing Multiple Sclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
PBR-06
Multiple Sclerosis
Brigham and Women's HospitalP1/2CC (45)
Pyruvate
Multiple Sclerosis
Ari GreenP2CC (45)
Methylreboxetine C-11
Multiple Sclerosis
Brigham and Women's HospitalP1/2CC (44)
Nbt-Nm108
Multiple Sclerosis
Suhayl Dhib-Jalbut, MDP1/2CC (44)
Pipe-307
Multiple Sclerosis
Contineum TherapeuticsP1CC (44)
Pipe-791
Multiple Sclerosis
Contineum TherapeuticsP1CC (44)
11c-bms-986196
Multiple Sclerosis
Bristol-Myers SquibbP1CC (43)
[ 18f]3f4ap
Multiple Sclerosis
Yale UniversityP1CC (43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Multiple Sclerosis
Beijing Boren HospitalP1CC (43)
bnt162b2
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CC (43)
Lcar-Aio T Cells
Multiple Sclerosis
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP1CC (43)
mk-6240
Multiple Sclerosis
Yale UniversityP1CC (43)
Universal Cd19 Car-Γδt Cell
Multiple Sclerosis
Tongji HospitalP1CC (43)
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Multiple Sclerosis
Ever Supreme Bio Technology Co., Ltd.P1/2CC (41)
Bendamustine
Multiple Sclerosis
Tr1X, Inc.P1/2CC (41)
Cilostazol
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P1/2CC (41)
Dantrolene
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P1/2CC (41)
Gadoteridol
Multiple Sclerosis
University of UtahEarly P1CC (41)
Mb-Cart2019.1
Multiple Sclerosis
Miltenyi Biomedicine GmbHP1/2CC (41)
Pioglitazone
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P1/2CC (41)
Pirfenidone
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P1/2CC (41)
trx319
Multiple Sclerosis
Tr1X, Inc.P1/2CC (41)
vt7208
Multiple Sclerosis
Vidya Therapeutics IncP1/2CC (41)
gsk3888130b
Multiple Sclerosis
GlaxoSmithKlineP1CC (40)
Lispro-Ph20 Component Rhuph20
Multiple Sclerosis
Hoffmann-La RocheP1CC (40)
lp-168
Multiple Sclerosis
Guangzhou Lupeng Pharmaceutical Company LTD.P1CC (40)
Lpx-Ti641
Multiple Sclerosis
LAPIX Therapeutics Inc.P1CC (40)
Mtr-601
Multiple Sclerosis
Motric BioP1CC (40)
Bcma Targeted Car T-Cells
Multiple Sclerosis
Tongji HospitalEarly P1C (39)
Lvivo-Tavec400 Product
Multiple Sclerosis
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEarly P1C (39)
Allogeneic Adipose-Derived Mesenchymal Stromal Cells (Ad-Mscs)
Multiple Sclerosis
Rennes University HospitalP1C (37)
Allorx
Multiple Sclerosis
The Foundation for Orthopaedics and Regenerative MedicineP1C (37)
Autologous Leukocytes, 89Zr-Oxine Labeled
Multiple Sclerosis
University of Alabama at BirminghamP1C (37)
azd0120
Multiple Sclerosis
AstraZenecaP1C (37)
Bms-986353 Is An Investigational Cd19-Targeted Car T-Cell Product. The Cd19-Specific Car Consists Of A Single-Chain Variable Fragment (Scfv) Binding Domain Derived From A Cd19-Specific Monoclonal Antibody (Mab; Fmc63), An Igg-Derived Hinge Region, A Cd28 Transmembrane Domain, And The Cd137 (41Bb) And Cd3? Chain Signaling Domains. The Third-Generation Sin Lentiviral Vector, Which Encodes The Car Domains Described Above, Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Expressed Separately From The Cd19 Car On The T Cell Surface
Multiple Sclerosis
Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyP1C (37)
Bryostatin 1
Multiple Sclerosis
Robert FoxP1C (37)
Cabozantinib
Multiple Sclerosis
National Cancer Institute (NCI)P1C (37)
Fludarabine Phosphate For
Multiple Sclerosis
St. Petersburg State Pavlov Medical UniversityP1C (37)
Glibenclamide
Multiple Sclerosis
University of Maryland, BaltimoreP1C (37)
Idp-023
Multiple Sclerosis
Indapta Therapeutics, INC.P1C (37)
ims001
Multiple Sclerosis
ImStem BiotechnologyP1C (37)
Intranasal Foralumab
Multiple Sclerosis
Tiziana Life Sciences LTDP1C (37)
Ipilimumab
Multiple Sclerosis
National Cancer Institute (NCI)P1C (37)
ivl3004
Multiple Sclerosis
Inventage Lab., Inc.P1C (37)
ivl4002
Multiple Sclerosis
Inventage Lab., Inc.P1C (37)
Kite-363
Multiple Sclerosis
Kite, A Gilead CompanyP1C (37)
Lu Ag06466
Multiple Sclerosis
H. Lundbeck A/SP1C (37)
Nivolumab
Multiple Sclerosis
National Cancer Institute (NCI)P1C (37)
Ocrelizumab Co-Formulated With Rhuph20
Multiple Sclerosis
Hoffmann-La RocheP1C (37)
Orca-Q
Multiple Sclerosis
Stanford UniversityP1C (37)
Showing 101 to 150 of 182 assets
PreviousPage 3 of 4Next